Excessive Supraventricular Activity and Atrial Fibrillation

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

February 15, 2028

Conditions
Atrial FibrillationAtrial FlutterSupraventricular Beat, PrematurePremature Supraventricular BeatsPremature Atrial ComplexExtrasystole, Atrial
Interventions
DIAGNOSTIC_TEST

Holter recording

Holter recording with Zenicor Flex ECG during 14 days.

DIAGNOSTIC_TEST

Echocardiography (Echo)

Echocardiography: Comprehensive transthoracic echocardiography with special focus on atrial dimension and function.

DIAGNOSTIC_TEST

Blood sample

Blood sample: 2 x 10 ml EDTA plasma sampled from venous blood at index and at 21 months. Troponin T, NTproBNP, Na, K, Creatinine. Sample for Biobank for future analysis.

DIAGNOSTIC_TEST

24 hour ambulatory blood pressure monitoring And Arteriograph

To assess artery stiffness.

Trial Locations (1)

Unknown

RECRUITING

Danderyd Hospital, Stockholm

All Listed Sponsors
collaborator

Danderyd Hospital

OTHER

lead

Karolinska Institutet

OTHER